Furthermore, the combination of multiple high-risk genotypes—including CYP1A1 rs4646903, GSTM1 deletion polymorphism, and ERCC2 Lys751Gln—elevates the risk of lung cancer by a factor of 5.94 (44). This evidence concerns the gene GSTM1 and lung carcinoma.